# Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

> **NCT01732068** · PHASE2 · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 51 (actual)

## Conditions studied

- Infertility
- Poor Ovarian Response

## Interventions

- **DRUG:** Triptorelin
- **DRUG:** Corifollitropin alfa
- **DRUG:** hpHMG

## Key facts

- **NCT ID:** NCT01732068
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732068, "Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01732068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*